2013
DOI: 10.1038/tpj.2013.16
|View full text |Cite
|
Sign up to set email alerts
|

Gene-expression differences in peripheral blood between lithium responders and non-responders in the Lithium Treatment-Moderate dose Use Study (LiTMUS)

Abstract: This study was designed to identify genes whose expression in peripheral blood may serve as early markers for treatment response to lithium (Li) in patients with bipolar disorder. Although changes in peripheral blood gene-expression may not relate directly to mood symptoms, differences in treatment response at the biochemical level may underlie some of the heterogeneity in clinical response to Li. Subjects were randomized to treatment with (n=28) or without (n=32) Li. Peripheral blood gene-expression was measu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
30
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 42 publications
(31 citation statements)
references
References 59 publications
1
30
0
Order By: Relevance
“…Few such studies to date have been undertaken using patient samples but rather cultured cells that have undergone immortalisation 3032 . Results so far have implicated, for example, apoptotic pathways 30,31 , neutral amino acid transport 30 , protein ubiquitination, and protein synthesis 32 .…”
Section: Introductionmentioning
confidence: 99%
“…Few such studies to date have been undertaken using patient samples but rather cultured cells that have undergone immortalisation 3032 . Results so far have implicated, for example, apoptotic pathways 30,31 , neutral amino acid transport 30 , protein ubiquitination, and protein synthesis 32 .…”
Section: Introductionmentioning
confidence: 99%
“…Beech et al [16] conducted studies of gene expression changes in peripheral lymphocytes in bipolar subjects on lithium treatment for 1 month as well as bipolar subjects prospectively treated with lithium for 6 months [17]. After 6 months of treatment, responders had a greater upregulation of antiapoptotic genes (BCL2) while proapoptotic genes were downregulated.…”
Section: Introductionmentioning
confidence: 99%
“…The fifth, GSE98793, compares the whole blood of major mood disorder patients with controls (Leday et al, ). The sixth, GDS5393, compares the peripheral blood of bipolar I patients before and after lithium treatment (Beech et al, ). Data were acquired already normalized and were not modified further.…”
Section: Methodsmentioning
confidence: 99%